Medtronic (MDT) Tops Q1 EPS by 9c, Raises EPS Guidance
Get Alerts MDT Hot Sheet
Price: $96.54 -0.59%
EPS Growth %: -2.2%
Financial Fact:
Cost of products sold: 1.13B
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: -2.2%
Financial Fact:
Cost of products sold: 1.13B
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q1 EPS of $1.41, $0.09 better than the analyst estimate of $1.32. Revenue for the quarter came in at $7.99 billion versus the consensus estimate of $7.85 billion.
GUIDANCE:
Medtronic sees FY2022 EPS of $5.65-$5.75, versus the consensus of $5.69.
- company continues to expect revenue growth in its fiscal year 2022 to approximate 9% on an organic basis
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Red River Bancshares, Inc. (RRBI) Tops Q3 EPS by 7c
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share